Friday, August 29, 2008

Controversy in the statin/cancer arena

A Medscape Today article just received (Aug 30, 2008) bears the heading: "FDA Looking Into Vytorin and Cancer Risk, but Interim Analysis Reassuring for Patients to Continue With Medication"

My previous blog entry refers to a NewsTarget article based on the Canadian Medical Association Journal article which states under 'Background' in the Abstract that
"The risk association between low-density lipoprotein (LDL) cholesterol and cancer remains controversial and largely unexplored for people not receiving statin therapy."

Now my interest is a bit more than academic. My post exactly one year ago Aug 30, 2007 (look it up) is titled "Cholesterol lowering statin drugs and Cancer! and summarizes some of my history, medically speaking, that puts me right in the middle of this topic having been a long time statin user to lower my cholesterol and during that "on statin" period of my life had 5 heart attacks and cancer.

In my humble opinion it is about time that this topic gets study and press to get it out in the open and before the public. Public exposure to this cannot hurt, only help individuals to take a proactive involvment in their own health issues. I Have!

Statins and cancer - again

NewsTarget author Byron J. Richards, a Board-Certified Clinical Nutritionist writes an article about the link between statin induced low cholesterol and cancer. His first paragraph opens this way...

"In a major shot fired across the bow of the statin marketing machine, the levels of LDL cholesterol that are the artificial targets of "health" promoted by the American Heart Association (AHA) are now found to be associated with a significant increased risk of cancer and death."

He further says...

"The Vytorin fraud has pointed out quite clearly that lowering LDL cholesterol to very low levels does not reduce cardiovascular disease. Another Vytorin study also shows doing so increases cancer risk by 64%. The new study paints the clear picture that lowering LDL too low actually increases the rate of death from any cause. This new study also points out the statistical shenanigans that the statin industry uses to hide the actual risks of these drugs in the studies that have been published."

Read the complete article here.

Link to full Canadian Medical Association Journal article here.